Assertio Holdings, Inc.
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Latest From Assertio Holdings, Inc.
Baxter’s management justified the deal by emphasizing the potential cost synergies and shared commitment to digital health innovation.
Predictions made by Kim Trautman, lead author of the US FDA’s Quality System Regulation, and four other top medtech experts regarding the agency’s upcoming harmonized QSR topped our list of most-read Medtech Insight articles in August.
Media reports indicate Baxter is negotiating to acquire Hillrom for about $10bn, but the companies are not commenting on the reports.
Baxter says customers complained of “multiple pumps within their fleets” encountering system errors after they made changes to their network configuration and server systems. It’s the second software-related setback for the device maker in recent weeks.
- Other Names / Subsidiaries
- Depomed, Inc.